Clinical trial
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
NCT00199537 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Completed
Key facts
| NCT number | NCT00199537 |
|---|---|
| Title | Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer |
| Official title | Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Collaborators | Lawson Health Research Institute Internal Review Fund University of Western Ontario, Canada |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostate Cancer, Bone Loss |
| Enrollment | 25 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 29, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: